Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
DDDr. Dereck Mush, MD, MBA
Jul 30
Perspectum
Quantitative medical imaging tools to diagnose and monitor metabolic liver diseases.
What they do
Perspectum develops advanced, non-invasive imaging software that measures liver fat, inflammation, and fibrosis from MRI scans. Used by clinical researchers and healthcare providers, the technology offers a precise alternative to liver biopsies for managing metabolic dysfunction-associated steatotic liver disease.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Quantitative metabolic imaging
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Oxford, UK
- Region
- Europe
- Founded
- 2012
- Total funding
- $135M raised
Notable investors: Oppenheimer Holdings, Blueush, HealthQuest Capital.
Also in Imaging & Diagnostics
Related on The Signal
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
DDDr. Dereck Mush, MD, MBA
Sep 13
Liquid biopsy monitoring is turning precision oncology into a continuous process, not a one time test
DDDr. Dereck Mush, MD, MBA
Jun 10
PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
DDDr. Dereck Mush, MD, MBA
Mar 19